Usefulness of prodromal unstable angina pectoris in predicting better survival and smaller infarct size in acute myocardial infarction (The InTIME-II Prodromal Symptoms Substudy)

Am J Cardiol. 2003 Sep 1;92(5):598-600. doi: 10.1016/s0002-9149(03)00732-x.

Abstract

Prodromal unstable angina on presentation is a significant predictor of smaller infarct size, reflected by smaller creatine kinase-MB and creatine kinase total measurements and lower 30-day, 6-month, and 5-year mortality. These findings suggest that prodromal unstable angina is an important physiologic marker that should be routinely collected for risk stratification.

MeSH terms

  • Angina, Unstable / complications*
  • Angina, Unstable / diagnosis*
  • Biomarkers / blood
  • Chi-Square Distribution
  • Creatine Kinase / blood
  • Creatine Kinase, MB Form
  • Female
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Isoenzymes / blood
  • Logistic Models
  • Male
  • Multivariate Analysis
  • Myocardial Infarction / diagnosis
  • Myocardial Infarction / drug therapy
  • Myocardial Infarction / etiology*
  • Myocardial Infarction / mortality*
  • Predictive Value of Tests
  • Prognosis
  • Prospective Studies
  • Risk Assessment / methods
  • Risk Assessment / standards
  • Risk Factors
  • Survival Analysis
  • Time Factors
  • Tissue Plasminogen Activator / therapeutic use
  • Treatment Outcome

Substances

  • Biomarkers
  • Fibrinolytic Agents
  • Isoenzymes
  • Creatine Kinase
  • Creatine Kinase, MB Form
  • Tissue Plasminogen Activator